Overview
Michela Relucenti practices practicing medicine in Rome, Italy.
Ms. Relucenti is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, Cholesteatoma, and Primary Lateral Sclerosis.
She is actively involved in clinical research, co-authoring 62 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Michela Relucenti
Is Michela Relucenti a top-rated expert for Doxorubicin-Induced Cardiomyopathy?
MediFind is an objective health platform that identifies experts based on real-world data. Michela Relucenti is classified as an Advanced expert for Doxorubicin-Induced Cardiomyopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Michela Relucenti participate in research or clinical trials?
Yes. Michela Relucenti has published 62 articles and abstracts on conditions like Doxorubicin-Induced Cardiomyopathy. You can view a list of Michela Relucenti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Doxorubicin-Induced CardiomyopathyMs. Relucenti isAdvanced. Learn about Doxorubicin-Induced Cardiomyopathy.
- Experienced
- Acute Monoblastic Leukemia (AmoL)Ms. Relucenti isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- AstrocytomaMs. Relucenti isExperienced. Learn about Astrocytoma.
- Brain TumorMs. Relucenti isExperienced. Learn about Brain Tumor.
- CalcinosisMs. Relucenti isExperienced. Learn about Calcinosis.
- Cardiomyopathy Due to AnthracyclinesMs. Relucenti isExperienced. Learn about Cardiomyopathy Due to Anthracyclines.
- CholesteatomaMs. Relucenti isExperienced. Learn about Cholesteatoma.
- Chronic Subdural HematomaMs. Relucenti isExperienced. Learn about Chronic Subdural Hematoma.
- Colorectal CancerMs. Relucenti isExperienced. Learn about Colorectal Cancer.
- Cystic FibrosisMs. Relucenti isExperienced. Learn about Cystic Fibrosis.
- DehydrationMs. Relucenti isExperienced. Learn about Dehydration.
- Epidermoid CystMs. Relucenti isExperienced. Learn about Epidermoid Cyst.
- GlioblastomaMs. Relucenti isExperienced. Learn about Glioblastoma.
- GliomaMs. Relucenti isExperienced. Learn about Glioma.
- Gliomatosis CerebriMs. Relucenti isExperienced. Learn about Gliomatosis Cerebri.
- MeningiomaMs. Relucenti isExperienced. Learn about Meningioma.
- OligodendrogliomaMs. Relucenti isExperienced. Learn about Oligodendroglioma.
- Primary Lateral SclerosisMs. Relucenti isExperienced. Learn about Primary Lateral Sclerosis.
- Subdural HematomaMs. Relucenti isExperienced. Learn about Subdural Hematoma.